The clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation: the LIFT prospective RCT

Background Long-term surviving liver transplant recipients can spontaneously develop operational tolerance, which allows them to completely discontinue their immunosuppression, but we lack validated tools to predict the likelihood of rejection following immunosuppression withdrawal. A previous clini...

Full description

Saved in:

Bibliographic Details
Main Authors:	Julien Vionnet, Rosa Miquel, Juan G Abraldes, Juan-Jose Lozano, Pablo Ruiz, Miquel Navasa, Aileen Marshall, Frederik Nevens, William Gelson, Joanna Leithead, Steven Masson, Elmar Jaeckel, Richard Taubert, Phaedra Tachtatzis, Dennis Eurich, Kenneth Simpson, Eliano Bonaccorsi-Riani, James Ferguson, Alberto Quaglia, Maria Elstad, Marc Delord, Abdel Douiri, Alberto Sánchez-Fueyo
Format:	Article
Language:	English
Published:	NIHR Journals Library 2025-04-01
Series:	Efficacy and Mechanism Evaluation
Subjects:	humans adult middle aged liver transplantation prospective studies arm berlin cause of death control groups elasticity imaging techniques incidence london prevalence weaning neoplasms immunosuppression therapy liver biomarkers outcome assessment health care transaminases allografts biopsy randomised controlled trials as topic multicentre studies as topic clinical trials phase iv as topic
Online Access:	https://doi.org/10.3310/FWXV5380
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

The clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation: the LIFT prospective RCT

Similar Items